Table 1 Baseline characteristics of the two study groups at baseline
Variables | Control group | NAFLD group | P value | |
|---|---|---|---|---|
Age (year), mean ± SD | 45 ± 10 | 47 ± 9 | 0.31 | |
Sex, N (%) | Female | 27 (67.5%) | 27 (67.5%) | 1.0 |
Male | 13 (32.5%) | 13 (32.5%) | ||
Residence, N (%) | Rural | 23 (57.5%) | 22 (55%) | 1.0 |
Urban | 17 (42.5%) | 18 (45%) | ||
Comorbidities, N (%) | Diabetes mellitus | 6 (15%) | 10 (25%) | 0.52 |
Diabetes/hypertension | 5 (12.5%) | 7 (17.5%) | ||
Gout | 1 (2.5%) | 1 (2.5%) | ||
Hypertension | 6 (15%) | 7 (17.5%) | ||
Hypothyroidism | 0 (0.0%) | 1 (2.5%) | ||
No | 22 (55%) | 14 (35%) | ||
Smoking, N (%) | No | 34 (85%) | 35 (87.5%) | 1.0 |
Yes | 6 (15%) | 5 (12.5%) | ||
BMI (kg/m2), mean ± SD | 30.8 ± 6.3 | 34.6 ± 4.3 | 0.012* | |
Fasting blood glucose (mg/dl), mean ± SD | 118.2 ± 32.91 | 108.7 ± 25.4 | 0.37 | |
HbA1C (%), mean ± SD | 7.77 ± 0.96 | 7.99 ± 0.43 | 0.41 | |
CAP (dB/m) | 190 ± 37 | 308 ± 53.3 | < 0.001* | |
LSM (kPa) | 5.2 ± 1.2 | 6.62 ± 1.5 | < 0.001* | |